Quantcast

Latest Aprepitant Stories

2014-07-15 08:23:19

New System Reduces Synthesis Time 25-Fold and Solvent Usage By 90% MATTHEWS, N.C., July 15, 2014 /PRNewswire/ -- CEM Corporation, a leading provider of microwave laboratory instrumentation, is pleased to announce that the Liberty Blue(TM) Automated Microwave Peptide Synthesizer is a winner of a 2014 R&D 100 Award. The award is presented on a yearly basis by the editors of R&D Magazine in recognition of the 100 most "technologically significant new products and processes of...

2014-02-11 20:21:26

DUBLIN, February 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tgtpbg/drug_solubility) has announced the addition of the "Concise Analysis of Drug Solubility Technology: Spray Drying, Extrusion, and SCF" [http://www.researchandmarkets.com/research/tgtpbg/drug_solubility ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) As drug suppliers re-examine their business models to adjust...

2014-01-29 16:29:05

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bgdzzw/tesaros) has announced the addition of the "Tesaro's Rolapitant: Competition for Emend" [http://www.researchandmarkets.com/research/bgdzzw/tesaros ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Tesaro's rolapitant is a NK-1 inhibitor in phase III trials for the prophylaxis of chemotherapy-induced nausea and...

2011-06-08 05:00:00

LONDON, June 8, 2011 /PRNewswire/ -- - New data presented at the European Hematology Association (EHA) 2011 Annual Meeting in London show better control of nausea and vomiting with the combination palonosetron plus aprepitant when compared to granisetron in patients receiving multiday highly emetogenic conditioning chemotherapy regimens - Significantly higher the complete response during the acute, delayed and overall periods The combination of palonosetron (0.25 mg iv every 48...

2010-10-13 07:00:00

NEW YORK and WHITEHOUSE STATION, N.J., Oct. 13 /PRNewswire-FirstCall/ -- Weight Watchers International, Inc., the world's leading provider of weight management services, and Merck, a global healthcare leader, announced today an innovative collaboration focused on fighting obesity. The two companies will launch an initiative in which Merck will provide physicians and other health care providers with educational information about the Weight Watchers® program and its...

2010-09-07 08:53:00

RYE, N.Y., Sept. 7 /PRNewswire/ -- Curemark (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that James F. Szigethy, formerly a consultant for Curemark, has assumed the position of Director of New Product Development. In his new position, Szigethy will have direct oversight of improving existing products and directing the development of new products. As Curemark continues to anticipate expansion of its clinical trials...

2010-07-02 16:23:00

WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ -- Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication. The FDA...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related